BioSpace News Archive

Biotech Bay

Biopharma Leaders Come Together at Veeva Commercial Summit to Advance Customer-Centric Engagement

Veeva Systems (NYSE: VEEV) today announced that leaders from Bayer, Genentech, Novo Nordisk, Takeda, and others will be among the keynote speakers at the 2024 Veeva Commercial Summit, May 7-8 in Boston.

April 17, 2024
·
3 min read
Business

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024

KORU Medical Systems today announced that the Company will report first quarter 2024 financial results on Wednesday, May 1, 2024.

April 17, 2024
·
1 min read
Biotech Bay

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) reports preliminary net revenue for its eyecare and wound care business for the first quarter of 2024 of $2.6 million, a 13% increase from the first quarter of 2023.

April 17, 2024
·
4 min read
Drug Development

Pantheon Vision Announces Two Successful Pre-Submission Meetings With the FDA

Pantheon Vision announced today the completion of two successful and productive Pre-Submission meetings with the U.S. Food and Drug Administration (FDA).

April 17, 2024
·
1 min read
Biotech Bay

Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting

Alterity Therapeutics today announced that three posters were presented at the American Academy of Neurology (AAN) 2024 Annual Meeting taking place April 13-18, 2024, in Denver, Colorado, USA.

April 17, 2024
·
12 min read
Business

Repligen to Report First Quarter 2024 Financial ResultsWebcast and Conference Call to Be Held Wednesday, May 1, 2024, at 8:30 a.m. ET

Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2024 financial results on Wednesday, May 1, 2024.

April 17, 2024
·
2 min read
Genetown

SaponiQx and InvivoGen Announce Agreement for SaponiQx to Supply Cultured Plant Cell QS-21 Adjuvant

Agenus today announced an agreement to supply InvivoGen with STIMULON cultured plant cell (cpc) QS-21.

April 17, 2024
·
2 min read
Drug Development

Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01

Evaxion Biotech A/S announces that the first patient in its EVX-01 Phase 2 trial in metastatic melanoma received the last vaccine dose in combination with KEYTRUDA® (NCT05309421).

April 17, 2024
·
4 min read
Business

Lipella Pharmaceuticals Expands its Advisory Board

Lipella Pharmaceuticals Inc. today announced the expansion of its Scientific Advisory Board to include oncology expertise.

April 17, 2024
·
3 min read
Bio NC

Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment

Science 37 Holdings, Inc. today announced the launch of a stand-alone Patient Recruitment Solution to deliver patients to sites that are eligible, medically reviewed, and fully consented.

April 17, 2024
·
2 min read